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Escherichia coli F-18, isolated from the feces of a healthy human, makes type fimbriae and is an excellent
colonizer of the streptomycin-treated mouse large intestine. Recently, it was shown that the inability to produce
type 1 fimbriae had no effect on the ability of E. coli F-18 to colonize the streptomycin-treated mouse large
intestine, suggesting the possibility that E. coli F-18 does not express type 1 fimbriae in vivo. However, we show
here that E. coli F-18 does express type 1 fimbriae in mouse cecal mucus in vivo and, in fact, appears to express
substantially more type 1 fimbriae in cecal mucus in vivo than in L broth in vitro.
Mannose-sensitive binding of Escherichia coli bearing
type 1 fimbriae to intestinal epithelial cells has long been
recognized (4, 5); however, the role of type 1 fimbriae in
intestinal colonization has been controversial. Studies of
neonatal diarrhea in pigs have shown the infectivity of
enterotoxigenic E. coli with the type 1 fimbriated phenotype
to be several times higher than that of the nonfimbriated
counterpart (9), yet other studies have shown that type 1
fimbriae are not produced by enterotoxigenic E. coli in the
pig small intestine during disease (10). In addition, it has
been recently reported that the loss of type 1 fimbriae in a
systemically invasive E. coli Ki strain did not alter its ability
to colonize the large intestines of neonatal rats but did result
in a drastic decrease in oropharyngeal colonization (1).
E. coli F-18, which was isolated from the feces of a healthy
human, is an excellent colonizer of the streptomycin-treated
mouse large intestine (2, 3). E. coli F-18 harbors the fim
operon and makes type 1 fimbriae (8). Furthermore, adhe-
sion of E. coli F-18 to specific glycoprotein receptors present
in cecal and colonic mucus and to cecal and colonic brush
border membranes can be inhibited by D-mannose (12),
suggesting that E. coli F-18 type 1 fimbriae may mediate
adhesion to intestinal mucosal components.
Recently, we reported that E. coli F-18 and E. coli F-18
FimA- (an isogenic strain which is unable to make type 1
fimbriae) could, when fed to mice simultaneously, colonize
the streptomycin-treated mouse large intestine equally well,
each strain persisting at approximately 107 CFU per g of
feces (8). These data provided clear evidence that the ability
to synthesize type 1 fimbriae was not a prerequisite for large
intestine colonization and suggested the possibility that E.
coli F-18 did not produce type 1 fimbriae in the large
intestine in vivo.
To test this hypothesis, cecal mucus was collected from
six streptomycin-treated mice colonized for 10 days with E.
coli F-18 and from six streptomycin-treated mice colonized
for 10 days with E. coli F-18 FimA-. Each sample was
placed in 5 ml of N-2-hydroxyethylpiperazine-N'-2-ethane-
sulfonic acid (HEPES)-Hanks buffer (pH 7.4), as described
previously (11). Each of the two samples was homogenized
in a Dounce homogenizer for 2 min. Forty-five milliliters of
* Corresponding author.
HEPES-Hanks buffer (pH 7.4) was then added to each
suspension. Each suspension was then left to settle for 20
min at 4°C. The top 45 ml of each suspension was withdrawn
and passed through cheesecloth to remove solid debris. The
suspensions were then centrifuged for 10 min (5,000 x g),
and the pellets were resuspended in 5 ml of HEPES-Hanks
buffer (pH 7.4). CFU per ml in each suspension was deter-
mined by plating on selective medium. Fimbriae were
sheared from the bacteria in each suspension by blending
five times for 1 min with 1-min intervals on ice. Bacteria
were then pelleted by centrifugation for 10 min at 7,710 x g,
leaving fimbriae in the supernatant. Urea was added to a final
concentration of 1 M, and each supernatant was then over-
laid on a 1 M urea-5 mM Tris-1 M sucrose cushion buffer
and subjected to ultracentrifugation (150,000 x g, overnight)
as described previously (6). The pellets were resuspended in
water and subjected to sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis, as described by Laemmli (7).
Proteins separated on the gel were transferred to nitrocellu-
lose and analyzed by Western blotting (immunoblotting) as
described by Krogfelt and Klemm (6). Free binding sites on
the nitrocellulose were blocked with 2% Tween 20, and the
nitrocellulose was incubated with specific anti-type 1 anti-
serum. Binding of anti-type 1 antibodies to the fimbrial
proteins was visualized by subsequent incubation with per-
oxidase-labeled goat anti-rabbit immunoglobulin G and tet-
ramethylbenzidine. The anti-type 1 antibodies utilized were
raised in rabbits against purified type 1 fimbriae by Krogfelt
and Klemm (6). Prior to utilization, the antiserum was
adsorbed with whole E. coli F-18 FimA- in order to remove
nonspecifically reactive antibodies.
Type 1 fimbrial subunits were observed in the cecal mucus
of mice colonized by E. coli F-18 but not in mice colonized
by E. coli F-18 FimA- (Fig. 1, lanes 3 and 4). Interestingly,
E. coli F-18 appeared to overexpress type 1 fimbriae in
mouse cecal mucus in vivo relative to the amount expressed
in vitro in L broth (Fig. 1, lanes 2 and 3). That is, judging
from the immunoblot signal, 107 CFU of E. coli F-18
obtained from cecal mucus in vivo appeared to produce
significantly more type 1 fimbrial subunits than 107 CFU of
E. coli F-18 grown standing in L broth at 37°C for 48 h and
added to cecal mucus. Also, during the type 1 fimbriae
purification procedure, 17-kDa (monomer) and 34-kDa (di-
mer) fimbrial subunits were copurified, yet for reasons which
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FIG. 1. Western blot analysis of type 1 fimbriae from E. ccli F-18
grown in vitro and in vivo. Lane 1, purified type 1 fimbriae, 1.5 p.g
of protein; lane 2, type 1 fimbriae purified from 10' CFU of
L-broth-grown E. ccli F-18 added to mucus from mice colonized by
E. ccli F-18FimA.lane 3, type 1 fimbriae from 107 CFU of E.clli
F-18 purified directly from mucus of mice colonized by E. ccli F-18;
lane 4, same purification procedure as in lane 3, but from mucus of
mice colonized by E. ccli F-18 FimA. The positions of protein
molecular mass standards (in kilodaltons) are indicated on the left.
are unclear, the dimer form appears to predominate when E.
coli F-18 is grown in L broth and added to cecal mucus (Fig.
1, lane 2), whereas the monomer form appears to predomi-
nate when type fimbriae are prepared from E. coli F-18
which have colonized cecal mucus (Fig. 1, lane 3).
In summary, despite the fact that type fimbriae are not
necessary for E. coli F-18 to colonize the streptomycin-
treated mouse large intestine (8), E. coli F-18 does express
substantial amounts of type 1 fimbriae in mouse cecal mucus
in vivo.
This work was upported byPcublic Health Service grant A116370
to P.S.C. and D.C.L. from the National Institute of Allergy and
Infectious Diseases.
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